Program Overview

We are pleased to advise a preliminary program. This will be updated as speakers and presentations are confirmed.

Thursday 13th June   
0830-1030
*some session start times vary
Structural Heart Disease
Meeting Room 1
SCT 1
Meeting Room 2
Registrar 1
Meeting Room 3
Nurse 1
*Meeting Room 4
 

CCDHB update
Alexander Sasse
0830 - 0840

Auckland update
Jonathan White
0840 - 0850

Waikato update
Sanjeevan Pasupati
0850 - 0900

Christchurch update
James Blake
0900 - 0910

Dunedin update
TBD
0910 - 0920

The minimalist TAVI
David Smyth
0920 - 0940

Alternative access
Sanjeevan Pasupati
0940 - 1000

Fast forward SHD to 2025
Lars Søndergaard
1000 - 1030

A rate related intraventricular conduction delay during exercise testing
(MTEC 2018 top case study)
Brooke Collins
0830 - 0840

Putting your behind
in the past
Graham Orsbourn
0840 - 0900

Future EP and cath lab
Erin Hooper
0900 - 0920

Future non-invasive monitoring and devices
Celeste Chang
0920 - 0940

Future echocardiography
Gillian Whalley
0940 - 1000

CPM and CCP
Ellen Woodcock
1000 - 1030

Everything you needed to know about the right heart studies
Andrew Aitken
0830 - 0900

Cardiac anatomy for the proceduralist
Matthew Webber
0900 - 0930

His pacing vs. CRT: What does the future hold?
Darren Hooks

0930 - 1000

Managing heart disease in pregnancy
Sarah Fairley
1000 - 1030

Introduction
Jennie Dean and Claudia Mercier
0900 - 0905

History of nursing and CSANZ
Jo-Ann Downie
0905 - 0925

TAS - a network supporting us all
Nick Fisher
0925 - 0945

The evolution of nurse-led clinics
Andy McLaughlin
0945 - 1010

A patient perspective
Rob Doughty
1010 - 1030

 

Chairs:

Phil Matsis and
Lars Søndergaard 

Belinda Buckley 

 Matthew O'Connor

Jennie Dean and
Claudia Mercier

1030-1100

Morning Tea - Shed 6 Arcade

1100-1230  Intervention
Meeting Room 1
SCT 2
Meeting Room 2
Registrar 2
Meeting Room 3
Nurse 2
Meeting Room 4
 

Shockwave plaque modification
Seif El-Jack
1100 - 1115

Coronary physiology beyond FFR
Jithendra Somaratne
1115 - 1130

Impella circulatory support: Hate it or love it 
David Smyth
1130 - 1200

Beyond CTO - management of the distal vessel
Scott Harding
1145-1200

Interventional / Structural Group business meeting
Seif El-Jack
1200 - 1230

Novel triggers of VT and AF
Peter Jones
1100 - 1120

Implementing the Abbott ConfirmRx Implantable Loop Recorder (ILR):
Does new technology improve workflow?
Sue Brett
1120 - 1135

Atrial fibrillation: New insights in mechanism and mapping
Jichao Zhao
1135 - 1150

High energy HIS-pacing devices
Lauren Clarke
1150 - 1205

Neuromodulation for VT in atrial fibrillation
Miguel Valderrabano
1205 - 1230

CSANZ trainee representation
Mayanna Lund
1100 - 1110

NZ fellowship and future NZ workforce needs
Mayanna Lund
1110 - 1130

How to choose and design a research project
Peter Larsen
1130 - 1200

New training requirement and training questions open session
James Blake, Peter Ruygrok, Michelle Sharp, Carolyn Lill, Mayanna Lund
1200 - 1230

Introduction
Jane Clarke and Chris Murphy
1100 - 1105

Managing patients with drug abuse and complex behaviour
Giles Newton-Howes
1105 - 1145

Methamphetamine-induced DCM case study
Naila Rahman
1145 - 1200

Priorities in nursing patients with AF
Jennie Dean
1200-1215

Exploring the barriers and enablers to up-titration of angiotensin-converting enzyme inhibitors in community heart failure patients from the primary care providers’ perspective
Suzanne Jackson
1215 - 1230

Chairs: 

 Seif El-Jack

Darren Hooks and Matthew Webber

 

 Matthew O'Connor

 Jane Clarke and
Chris Murphy

1230-1330  Lunch - Shed 6 Arcade
1230-1330 Rehab Working Group Meeting - Meeting Room 4
1300-1330 Affiliate AGM - Meeting Room 3
1330-1530 Teleflex Workshop - TSB Arena, APW Room (Level 1)
 

Wellington hospital’s experience with Turnpike Microcatheter, with an introduction to TrapLiner & SuperCross
Dr Scott Harding & Mr Kevin Dahlgren
From 1330    

For further information about this session, please click here.

1330-1530

Joint Session: Indigenous Cardiac Health (ICH) Conference
Meeting Room 1

Electrophysiology - VT Symposium 1

Meeting Room 2

Imaging

Meeting Room 3

Prevention

Meeting Room 4

 

Modifiable risk factors for ARF in New Zealand
Michael Baker
1330 - 1355

New Zealand
school screening / NZ registry
Rachel Webb
1355 - 1415

The lived experience of ARF/RHD
Anneka Anderson
1415 - 1430

Rheumatic heart disease - a global perspective
Bo Remenyi
1430 - 1445

Cardiothoracic surgery
and valvular repairs in Indigenous Australians: The Flinders experience
Jayme Bennetts
1445 - 1500

Surgical repair or replacement for rheumatic mitral valve disease
Tom Wang
1500-1515

Panel discussion: 
The road ahead to eliminate rheumatic heart disease 
1515-1530

History of VT ablation in NZ
Nigel Lever
1330 - 1350

VT management
for the non-EP
Matthew
Webber
1350 - 1410

Surgeons help
reach the summit
Martin Stiles
1410-1430

Reaching the
LV summit alone
Miguel Valderrabano
1430-1450

Use of ICE and image integration for VT ablation
Jamie Voss
1450 - 1510

LQTS - treat with ICD 
or b-blocker?
Kenichiro Yamagata
1510 - 1530

 

What's new in CMR?
Online Stream
Christian Hamilton-Craig
1330 - 1345

Predicting progression of coronary artery calcification with 18F-sodium fluoride positron emission tomography-computed tomography
Philip Adamson
1345 - 1400

LV function: 20/20 vision
Gillian Whalley
1400 - 1415

Underutilisation of contrast enhancing agents in stress echocardiography decreases the quality of this investigation - a lesson still to be learnt
Kerryanne Johnson
1415 - 1430

Role of echo contrast
James Pemberton
1430 - 1445

Massive and torrential TR - new grading
Alexander Sasse
1445 - 1500

Imaging Business Meeting
1500-1530

Introduction
1330 - 1335

Managing cardiovascular disease from
a GP perspective
Chris Masters

1335 - 1400

Cardiac rehab - the past, the present, the future 
Jocelyn Benatar
1400 - 1420

Heart Foundation: Supporting patients
and clinicians
Rochelle Mellsop
1420 - 1450

Cardiac rehab:
Patient case study
Rachel Hall
1450 - 1510

Do patients understand cardiac education?
A New Zealand review
Kylie Short
1510 - 1530

Chairs:

Alex Brown and
Mayanna Lund 

Andrew Martin and
Miguel Valderrabano

Russell Anscombe and
Andrew To

Sam Bowman

1530-1600 Afternoon Tea - Shed 6 Arcade
1600-1730

  Electrophysiology - VT Symposium 2
Meeting Room 2
Intervention - Learning the Techniques  
Meeting Room 3
Heart Failure
Meeting Room 4 
 

 

Ischaemic VT: Where and how much to ablate?
Andrew Martin

1600-1620

Idiopathic VT
Matthew Webber
1620-1640

VT with difficult access
Darren Hooks
1640-1655

Brugada syndrome - nothing, Ajmaline, ICD, or ablation? Kenichiro Yamagata
1655-1715

Wrap up and discussion
1715-1730

 How to use IVUS
in the cath lab
Scott Harding and Nigel Jepson
1600-1645

How to use OCT
in the cath lab
Scott Harding and Nigel Jepson
1645-1730

  Welcome
1600-1605

Entresto - the Waikato experience
Debbie Chappell and Eileen Gibbons
1605-1630

Palliative care in heart failure - 20 years on
Brigitte Lindsay
1630-1650

Your main test is an echo
to look at the LV
Paul Bridgman
1650-1710

Heart Failure
Registry update
Raewyn Fisher
1710-1715

Business Meeting
1715-1730

Chairs:

 

Iain Melton

Scott Harding and Nigel Jepson

Raewyn Fisher 

1730-1900 Welcome Reception and Moderated Oral Poster Presentations, Exhibition Hall
1930 Bio-Excel Evening Symposium
 

From 1930hrs

Tools and techniques to optimise complex PCI
Scott Harding

CSI diamond back, new Kid on the block for calcified lesions
Aniket Puri

For further information about this session, please click here.

 

Friday 14th June
0730-0845 Novartis Breakfast Symposium
Meeting Room 4
Philips Breakfast Symposium 
Meeting Room 3
 
 

Breakfast served
0730-0745

The ‘stable’ heart failure patient...and beyond
Pardeep Jhund
0745-0845

For further information about this session,
please click here.

Breakfast served
0730-0745

GPS – guided physiological stenting: A new paradigm
Nigel Jepson, Aniket Puri and David Smyth
0745-0845

For further information about this session,
please click here.

 

0900-1030
Opening Plenary - Young Investigator Award Finalists
Meeting Room 1

 

Conference opening
Mayanna Lund and Alexander Sasse
0900 - 0915

Heart Foundation Lecture: Bench to bedside: A PCI tale
John Ormiston
0915 - 0945

A cross-over study of hyperventilation anxiety in stress cardiomyopathy and control patients
George Watson
0945 - 1000

Platelet Toll-like Receptor (TLR) expression and TLR-mediated platelet responses in healthy and acute myocardial infarction (AMI) subjects
Kathryn Hally
1000 - 1015

Clinical applications for artificial intelligence on a multi-dimensional cardiology dataset
Nicholas James
1015 - 1030

Chairs:

Gerry Devlin and Mayanna Lund

1030-1100
Morning Tea - Exhibition Hall
1100-1230 Philips Workshop - Meeting Room 4
 

iFR vs Angio mismatch - how to decide on treatment strategy 
Nigel Jepson & Aniket Puri
1100-1140

Is IVUS hyped or needed?
David Smyth and Robert Gerber
1145-1230

For further information about this session, please click here.

1100-1230 Structural Heart Disease
Meeting Room 1

Pulmonary Hypertension
Meeting Room 2

Affiliate Investigator
Award Finalists
Meeting Room 3
 

 

Transcatheter aortic valve implantation - a paradigm shift
Lars Søndergaard
1100 - 1145

TAVI case
Panel
1145 - 1200

TAVI - minimising procedural complications
Jonathan White
1200 - 1215

The other values...
Rajesh Nair
1215 - 1230

Pulmonary hypertension therapy in NZ: Current status and future developments
Ken Whyte
1100 - 1115

Pulmonary hypertension in ACHD
Andrew Aitken
1115 - 1130

Pulmonary hypertension in left heart disease
Cara Wasywich
1130 - 1145

Serial right heart catheterisations in the assessment of
porto-pulmonary hypertension
Arthur Coverdale
1145 - 1200

Progression of acute rheumatic fever to recurrence, rheumatic heart disease and death in New Zealand children and youth: A cohort study
Jane Oliver
1200-1215

Performance of risk models predicting cardiac complications in pregnant women with congenital heart disease: A meta-analysis
Tom Wang
1215-1230

Introduction
1100 - 1110

Review of IV amiodarone administration to reduce the occurrence of phlebitis
Siobhan Seeney
1110 - 1130

Audit of management post-ACS with at least moderate LV impairment in Counties Manukau: Room for improvement
Andy McLachlan
1130 - 1150

Catheter ablation of cavotricuspid isthmus-dependent atrial flutter: Initial experience with the 8mm IntellaTip MiFi catheter
Erin Hooper
1150 - 1210

Cardiac rehabilitation in Wellington: Influence of a comprehensive exercise-based 12-week course on key indicators (2017-19)
Samantha Bowman
1210 - 1230

 

Chairs:

Rajesh Nair and
Mark Webster 

Julie Chirnside and
Timothy O'Meeghan

Belinda Buckley and
Jo-Ann Downie

 
1230-1330
Lunch - Exhibition Hall
1230-1330
ANZACS QI Meeting - Meeting Room 3
1230-1330
CSANZ Committee Meeting - TSB Wellington Room
1330-1500 Acute Coronary Syndromes - Role of CTCA in Modern Practice
Meeting Room 1
Congenital Heart Disease
Meeting Room 2
Electrophysiology - General
Meeting Room 3
 

 

Best use of CTCA in modern hospital practice
Andrew To
1330 - 1400

FFRct ready for clinical practice?
Online Stream
Christian Hamilton-Craig
1400 - 1415

Safety and efficacy if Computer Tomography Coronary Angiography (CTCA) in a remote centre for outpatients otherwise requiring Invasive Coronary Angiography (ICA) for chest pain assessment
Kerryanne Johnson
1415 - 1430

Long-term outcomes of very elderly patients undergoing percutaneous coronary intervention for acute coronary syndromes
Bernard Wong
1430 - 1445

Acute coronary syndromes complicated by cardiogenic shock: Wellington Hospital outcomes to one year
Thalib Mowjood
1445 - 1500

Tetralogy of Fallot with free pulmonary regurgitation: Are we too late?
Lars Søndergaard
1330 - 1400

Melody valves: The NZ experience
Clare O'Donnell
1400 - 1420

ACHD: What does the Electrophysiologist have to offer?
Darren Hooks
1420 - 1440

Surgery in ACHD: Who, when and where
Kirsten Finucane
1440 - 1500

 Inappropriate sinus tachycardia: Diagnosis and management
Miguel Valderrabano
1330 - 1400

How to ICE guide for electrophysiologists
Kenichiro Yamagata
1400 - 1420

Regional variation in permanent pacemaker and implantable cardioverter defibrillator implant trends in New Zealand
Fang Shawn Foo
1420 - 1435

Catheter versus thoracoscopic ablation for atrial fibrillation: A meta-analysis of randomised trials
Tom Wang
1435 - 1450

Debate: Everyone should have a HIS lead

FOR: 
Darren Hooks
1450 - 1510

AGAINST: 
Dean Boddington
1510 - 1530

 

Chairs:

Mark Simmonds

John Lainchbury and
Graeme Porter

Miguel Valerrabano and
Jamie Voss

1500-1530
Afternoon Tea - Exhibition Hall
1530-1700
SCT Meeting - TSB Wellington Room
1530-1700 Intervention - Precision PCI
Meeting Room 1
Cardiac Transplant Session
Meeting Room 2
Aorta
Meeting Room 3
 

 

Physiological assessment of CAD - the new standard
Gerry Devlin
1530 - 1545

Latest in coronary physiology -
update of resting indices
Nigel Jepson
1545 - 1600

Shockwave intravascular lithotripsy for calcified coronary lesions: First real-world experience
Bernard Wong
1600 - 1615

IVUS in complex PCI -
the data is clear
Sarah Fairley
1615 - 1630

How to perform some common bifurcation stenting techniques.
Step by step
John Ormiston
1630 - 1645

Ultra-low / zero contrast PCI
Scott Harding
1645 - 1700

 

A heart transplant patient's journey
Tom Pasley
1530 - 1545

Referral - who and when
Sarah Fitzsimmons
1545 - 1600

Psychosocial assessment - why is it so important?
Iris Fontanilla and Michael Stubbs
1600 - 1630

Follow up and outcomes
Cara Wasywich
1630 - 1645

Panel discussion
1645 - 1700

 

Aortic disease: Types, incidence and investigation
Mark Simmonds
1530 - 1555

Surgery for type-A aortic dissection: A 14-year contemporary cohort study
Thomas Evans
1555 - 1610

Endovascular treatment of aortic disease
Lupe Taumopeau
1610 - 1635

Surgical treatment
of aortic disease
Online Stream
Sean Galvin
1635 - 1700

 

Chairs:

Scott Harding and
John Ormiston

Katherine Ferrier and
Peter Ruygrok

Sean Galvin and
Mark Simmonds 

1700-1800
CSANZ AGM, Meeting Room 3
From 1900
Gala Dinner

 

Saturday 15th June
0715-0830 Abbott Breakfast Symposium
Structural heart in 2019 and beyond
Meeting Room 4
Biosense  Breakfast Symposium
EP - Emerging Technologies
Meeting Room 3 
 

 

Breakfast served
0715-0730

LAA occlusion for stroke prevention evidence, patient selection
Lars Søndergaard
0730-0755

Transcatheter mitral valve repair evidence, indication, case in the box
Rajesh Nair and Sanjeevan Pasupati
0755-0830

 For further information about this session, please click here.

Breakfast served
0715-0730

Point-by-point PVI Qdot style
Andrew Martin
0745-0800

Emerging RF balloon technologies for PVI
Geoffrey Clare
0800-0815

The Implantable Cardioverter Defibrillator – are we there yet?
Iain Melton
0815-0830

 For further information about this
session, please click here.

   

 

0900-1030 Multivessel Coronary Artery Disease -
PCI or CABG
Meeting Room 1
Acute Coronary Syndromes - MINOCA etc
Meeting Room 2
Heart Failure 
Meeting Room 3
 

Role of PCI in 2019 - utility and future of FFR
Ali Khan
0900 - 0920

CABG in 2019
Brecon Wademan
0920 - 0945

Case-based discussion
Malcolm Abernethy
0945 - 1000

Dual antiplatelet therapy in high-risk clinically stable coronary artery disease: A randomised controlled trial
Philip Adamson
1000 - 1015

Frailty in very elderly patients undergoing percutaneous coronary intervention for acute coronary syndromes
Bernard Wong
1015 - 1030

SCAD in 2019
Aniket Puri
0900 - 0920

Takotsubo syndrome
Christina Chan
0920 - 0940

MINOCA
Sean Coffey
0940 - 1000

Borderline coronary physiology – outcomes of patients with a negative instantaneous wave-free ratio
Charlotte Greer
1000 - 1015

Acute coronary syndrome incidence, procedures and mortality outcomes in New Zealand 2006-2016: ANZACS-QI 27 nationwide data linkage study
Tom Wang
1015 - 1030

The cardiac patient in ICU
James Moore
0900 - 0915

Cardio-oncology
Kate Clarke
0915 - 0930

Methamphetamine-associated cardiomyopathy versus other non-ischaemic cardiomyopathies: A case-controlled study
Tom Wang
0930 - 0945

Improving detection of familial dilated cardiomyopathy by systematic screening
Michael Stubbs
0945-1000

From the heart to heart failure: A short history
Hamid Ikram
1000-1030

 

 

 

Chairs:

Malcolm Abernethy, 
Harvey White 

Sarah Fairley,
Aniket Puri

Katherine Ferrier and Raffat Shameem

1030-1100 Morning Tea - Exhibition Hall
1100-1230 Electrophysiology
Meeting Room 1
Structural Heart Disease
Meeting Room 2
Prevention
Meeting Room 3
 
 

Tips and tricks for the 12-lead ECG,
and who to refer
Iain Melton
1100 - 1130

AF ablation - what the Generalist needs to know
Miguel Valderrabano
1130 - 1200

Implanted device secrets for non-EPs
Martin Stiles
1200 - 1230

 

Mitral valve and PTMC
Phillip Matsis
1100 - 1115

Mitral valve surgery for primary or secondary mitral valve disease: An eight-year comparative cohort study
Tom Wang
1115 - 1130

Results from the first hundred percutaneous patent foramen ovale closures in Christchurch
Cameron McAlister
1130 - 1145

Mitra clip results - is New Zealand missing out?
Lars Søndergaard
1145 - 1200

Tricuspid valve
Rajesh Nair 
1200 - 1215

In 10 years
Mark Webster 
1215 - 1230

Introduction
1100-1105

Heart failure in congenital adult population
Jane Hannah
1105-1125

LDL in the 2020's:
How low is too low?
Harvey White
1125-1150

Cardiac rehabilitation in New Zealand - moving forward with clinical exercise physiology
Sonja Dreyer and
Lukas Dreyer
1150-1210 

Managing health-related anxiety in cardiac rehabilitation
John Moffat
1210-1230

Chairs

 

Peter Ruygrok and
David Smyth

Tom Donoghue and
Janet Dunbar

1230-1330 Lunch - Exhibition Hall
1330-1500 Imaging
Meeting Room 1
Acute Coronary Syndromes - Contemporary Anti-Platelet Management  
Meeting Room 2

 

Artificial intelligence in echocardiography for standard clinical metrics
William Hewitt
1330 - 1345

Aortic stenosis for beginners
Andrew To
1345 - 1400

Aortic regurgitation
James Pemberton
1400 - 1415

Can non-invasive myocardial work index calculation improve the accuracy of exercise stress echocardiography?
Andrew Borrie
1415 - 1430

3D Echo
Alexander Sasse
1430 - 1445

Infiltrative cardiomyopathies
Josh Martin
1445 - 1500

Optimal DAPT in ACS - shorter, longer?
Harvey White
1330 - 1345

Optimal DAPT following PCI in stable CAD?
Jithendra Somaratne
1345 - 1400

Optimal antithrombotic therapy in ACS and AF?
Michael Williams
1400 - 1415

Antithrombotic strategy for patients with anticoagulation indication undergoing percutaneous coronary intervention: Meta-analysis of randomised controlled trials
Becky Liao
1415 - 1430

Contemporary audit of prescribing patterns
following coronary artery bypass grafting
Danting Wei
1430 - 1445

Should all patients post-CABG receive DAPT?
Gerry Devlin
1445 - 1500

  

Chairs:

Timothy O'Meeghan and
Gillian Whalley

Harvey White and 
Mike Williams

1500-1515
Conference Close - Meeting Room 1

 

 

Conference close
Alexander Sasse

 

Please note this program is subject to change.

© 2019 CSANZ | Conference is managed by The Conference Company

Designed & Developed by 72DPI